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2. Problem Identification
• In treatment of patients with substance use disorder, family medicine physicians can work 
closely with a multidisciplinary medication assisted treatment (MAT) team, providing 
recovery support alongside medical care.  These teams have expertise in community 
resources, drug screening, withdrawal, and psychological counseling.  Physicians often need 
to direct patients to MAT programs.
• Reference material on MAT can be widely distributed, with multiple sources often consulted 
for a patient with substance use disorders, including morphine equivalents, urine drug 
screening, and tapering strategies.
• Time is short in the clinic, and a single resource that could provide contact information for 
MAT resources alongside frequently cited medical information could expedite care.  This 
would be doubly valuable for physicians new to the region.
3. Public Health Cost
• Opioid related fatalities in Vermont have nearly 
tripled since 2010, 110 deaths in 2018, driven in part 
by fentanyl fatality increases.
• 2.6% of Vermonters between 18 and 64 years old 
participated in MAT programs in 2018. 
• MAT availability has increased such that supply has 
now met demand, without wait times prior to hub 
services.  Focus is now on increasing entry points, 
such as emergency rooms, i.e. the Rapid Access to 
MAT (RAM) program.
Medication Assisted Treatment for Opioid Use Disorder Trends, 
2019, https://www.healthvermont.gov/
Opioid Related Fatalities among Vermonters, February 2019 
https://www.healthvermont.gov/
4. Community Perspective on Issue
• A design input solicitation email was sent to practitioners at Berlin Family Practice, seeking 
information they frequently reference for MAT patients, either medical information or 
community resources.
• Interviews were conducted with several stakeholders involved with MAT patients, 
specifically asking them about content and application of a single-sheet double sided  
Desktop Reference.
• Laurie Hansen, MAT RN, CVMC – Provided substantial content for both the physician fact sheet side (Narcan dosages and 
acquisition, screening guides such as COWS for withdrawal screening and OBOT Stability Index) as well as detailed patient 
resources for where they can find aid.  This included the hub procedures at facilities like BAART Program, Rapid Access to 
MAT (RAM) program at which patients can receive immediate assistance while in withdrawal, and Treatment Associates 
which “operates like something between a hub and a spoke.”
• Jeremiah Eckhaus, MD, CVMC – Discussed how such a document could be used by family medicine physicians throughout 
the state, in either hardcopy or electronic format.  He suggested that with the integration of more facilities into the UVM 
Health Network and the EMR, the resource document could be made available as a software add-on. “This is the sort of 
thing that if it was widely adopted could be added to Epic.”
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• The drafted Vermont Medication Assisted Desk 
Reference is a single 2-sided sheet, intended to 
be laminated and available for everyday use.
• The greatest challenge was deciding what could 
be included in limited space.
• One side, the healthcare provider fact sheet has 
medical information often used by physicians:
• Morphine equivalents 
• Urine detection timetables
• Tapering rates
• Severity indices
• Appropriate links for comprehensive 
information
5B. Intervention
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• The second side, the patient fact sheet includes a 
number of features relevant to the patient 
themselves:
• Locations and contact numbers for MAT hubs 
throughout the state
• Where one can go while currently in 
withdrawal, including a description of Rapid 
Access to MAT, an emergency room program 
available for actively withdrawing patients.  
This also includes the crisis text line.
• Sources for naloxone, including a link to the 
online map service provided by the state, and 
recommendations for naloxone usage.
6A Results – Design Feedback
• An online design review was conducted, soliciting feedback from MAT stakeholders, with 
generally positive response and suggestions for future iterations:
• “This is something which is going to be used.  Even just the windows for detection of 
drugs in urine are very useful.” – Dale Stafford, Family Physician
• “Good, short document.  Easy to read and has useful information.  The table with 
metabolites and half lives is clinically relevant.” – Jose Lopez, Family Physician
• “I would also add induction protocols and how long the presence of illicit substances 
(such as cocaine) are in the urine.” – Anonymous, Vermont physician with MAT 
experience
• “I think it is important to even briefly mention that the 2 part Hub and Spoke includes 
counseling and recovery support.” – Katina Cummings, MCP, Health Workforce 
Program Manager, Northern Vermont AHEC
6B Results – 2nd Design Iteration
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• Drafts were distributed to contributors to the 
design process, and an early request was 
received to make a second version of the desktop 
reference focused on Central Vermont’s MAT 
resources, which is shown here.
• While having an identical physician fact sheet, 
the patient fact sheet of this version has local 
MAT induction information, including walk-in 
clinic hours most relevant for central Vermont.
7A. Evaluation of Effectiveness and Limitations
• As the MAT Desktop Reference is an easily distributable document, in either hardcopy or 
electronic format, an evaluation of its usefulness could be conducted through distribution to 
stakeholders through an online survey.  This could include PCPs and MAT professionals.
• Information solicited in these surveys should include:
• Assessment of perceived value of the medical information from the provider fact sheet 
(quantized for each section)
• Assessment of perceived value of the patient fact sheet (quantized for each section)
• Suggestions for information that should be added 
• Suggestions for information that is not necessary  
8. Opportunities for Future Interventions
• Distribution of this, or an abridged MAT reference, to school health 
professionals, such as school nurses, to improve treatment for youth 
opioid use disorder.
• Augmented references focused on individual counties and their 
particular needs.
• Alternative desk references in a similar style produced for other 
community health issues, such as medical supply availability or home 
health services.
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VERMONT MEDICATION ASSISTED TREATMENT
HEALTHCARE PROVIDER FACT SHEET
DSM-5 Criteria for Opioid Use Disorder
A pattern of opioid use leading to clinically significant 
impairment or distress, as manifested by at least 2 of the 
following within a 12-month period.  Severity as follows:
Mild: Presence of 2-3 symptoms   
Moderate: Presence of 4-5 symptoms  
Severe: Presence of 6 or more symptoms
1. Opioids are often taken in larger amounts or over a 
longer period than was intended. 
2. Persistent desire or unsuccessful efforts to cut down 
or control opioid use. 
3. A great deal of time is spent in activities necessary to 
obtain, use, or recover from the effects of opioids. 
4. Craving, or a strong desire or urge to use opioids. 
5. Recurrent opioid use resulting in a failure to fulfill 
major role obligations at work, school, or home. 
6. Continued opioid use despite having persistent or 
recurrent social or interpersonal problems caused or 
exacerbated by the effects of opioids. 
7. Important social, occupational, or recreational activi-
ties are given up or reduced because of opioid use. 
8. Recurrent opioid use in situations in which it is physi-
cally hazardous.  
9. Continued opioid use despite knowledge of a per-
sistent/recurrent physical or psychological problem like-
ly to have been caused or exacerbated by the substance. 
10. Tolerance.
11. Withdrawal.
abridged from Diagnostic and Statistical Manual of Mental Dis-
orders, 5th edition, 2013
COWS
The Clinical Opiate Withdrawal Scale is a pen and paper 
severity scale based up common withdrawal symptoms, 
obatinable through multiple sources, including the link 
below.  5-12 = mild; 13-24 = moderate; 25-36 = moder-
ately severe; more than 36 = severe withdrawal
American Society of Addiction Medicine
https://www.asam.org/
Tapering Guidelines
• Common tapers - 5% to 20% reduction every 4 weeks
• Slower tapers - 10% per 4 weeks, better tolerated
• Fast tapers - 10% per week until 30% of original dose 
is reached, then 10% of remaining dose
• Rapid taper - Over 2-3 weeks, may be appropriate if 
risks of continued use outweigh risk of withdrawal
• Ultrarapid detox under anesthesia - high risk and 
should not be used
• Dysphoria, insomnia, and irritability may take weeks 
or months to resolve
• Alpha-2-agonists may be used for management of 
autonomic symptoms such as tachycardia.
HHS Guide for Clinicians on the Appropriate Dosage Reduction 
or Discontinuation of Long-Term Opioid Analgesics, 
US Department of Health and Human Services, October 2019
Morphine Equivalent Units/Detection Timetable
Buprenorphine
film/tab (mg)
Codeine
Fentanyl 
derm(mcg/hr)
Hydrocodone 
Hydromorphone 
Methadone
• 1-20 mg/d 
• 21-40 mg/d 
• 41-60 mg/d 
• ≥ 61-80 mg/d
 
Morphine 
Oxycodone 
Oxymorphone  
“Calculating Daily Total Dose of Opiods for Safer Dosage,” www.
cdc.gov, August 2019
Kale, N. “Urine Drug Tests: Ordering and Interpretation,” Amer-
ican Family Physician, 2019 Jan 1;99(1):33-39
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Urine Detectability/Analyte
•11 days - metabolite norbu-
prenorphine
• 1-2 days - hydromorphone 
and morphine
•2-3 days - norfentanyl
• 1-2 days - hydromorphone
• 1-2 days - hydromorphone
•3-4 days (as high as 14 days) 
- 2-ethylidene-1,5-dimeth-
yl-3,3-diphenylpyrrolidine
• 3 days - Codeine, hydromor-
phone, 6-MAM, morphine
• 1-3 days - Noroxycodone, 
noroxymorphone, oxycodone, 
oxymorphone
•1.5-4 days - Noroxymor-
phone, oxymorphone
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VERMONT MEDICATION ASSISTED TREATMENT
STATEWIDE PATIENT FACT SHEET
I’m in withdrawal right now.  What can I do?
If you’re in crisis, you can reach the Vermont Crisis text 
line.  Text VT to 741741.
Rapid Access to MAT (RAM) is a program available at 
many emergency departments across the state, includ-
ing UVMMC, CVMC, and Rutland.  RAM allows for 
same-day treatment with buprenorphone to control 
withdrawal, while you are referred to a MAT provider 
and connected with a Recovery Coach.  Questions about 
RAM and whether it’s available in an emergency room 
near you can be answered by the confidential clinician’s 
line, (802)371-4190.
Rapid Access to MAT, https://cvmc.org/our-services/emergen-
cy-department/rapid-access-mat-ram
Where can I get Narcan®/naloxone?
WARNING - You may need two or more doses 
available.  It’s advisable to have multiple naloxone doses 
on hand, due to the overdose potential of fentanyl and 
fentanyl-contaminated drugs.  It is not uncommon for 
a person in overdose to respond to a first dose of nalox-
one only to lose consciousness once again and require a 
second dose.  
WARNING - Call 9-1-1 after administering a dose of 
Narcan to anyone.  The person may not be stable, and 
it’s state law to help keep them safe.  You are immune 
from civil or criminal liability when giving naloxone, so 
long as you don’t act recklessly, with gross negligence, or 
intentional misconduct.
Where you can get naloxone:
•  All pharmacies in Vermont are required to make 
naloxone available on request, but there may be some 
charge.  Medicaid or insurance may apply.  
•  The Opioid Overdose Prevention and Reversal Project 
makes emergency overdose rescue kits  and overdose 
response training available free of charge at a range of 
locations.  A list and map of locations may be found at 
the web address below.
NARCAN/NALOXONE OVERDOSE RESCUE
https://www.healthvermont.gov/response/alcohol-drugs/nar-
can-naloxone-overdose-res
Where can I begin MAT?
You can receive live help to find treatment programs by 
dialing 2-1-1 in Vermont or visiting Vermont211.org.
Medication Assisted Treatment (MAT) uses a “hub-and-
spoke” model and starts at an Opioid Treatment Hub, 
where you will be evaluated and begin receiving medica-
tions such as buprenorphine to prevent withdrawal and 
reduce cravings.  Eventually, your medications will be 
managed at the “spoke” office that is most convenient for 
you.  Please bring ID and be prepared to submit a urine 
sample - the screening evaluation takes 1-2 days.  Hubs 
where you can begin treatment are listed below:
Chitenden county
• Howard Center, Burlington and South Burlington 
(802)488-6425
Franklyn and Grand Isle Counties
• BAART Behavioral Health Services, St. Albans 
(802)370-3545
Orleans, Essex, & Caledonia County
• BAART Behavioral Health Services, Newport 
(802)334-0110
• BAART Behavioral Health Services, St. Johnsbury 
(802)748-6166
Rutland County
• West Ridge Center for Addiction Recovery, Rutland 
(802)776-5800
Washington County
• Central Vermont Addiction Center, Berlin 
(802)223-2003
Windham County
• Brattleboro Retreat, Brattleboro 
(802)257-7785
• Habit OpCo, Brattleboro 
(802)349-1880
New Hampshire
• Habit OpCo, West Lebanon 
(603)298-2146
“Vermont Substance Abuse Treatment & Recovery Directory”
Division of Alcohol & Drug Abuse Programs
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VERMONT MEDICATION ASSISTED TREATMENT
CENTRAL VT PATIENT FACT SHEET
I’m in withdrawal right now.  What can I do?
If you’re in crisis, you can reach the Vermont Crisis text 
line.  Text VT to 741741.
Rapid Access to MAT (RAM) is a program available at 
many emergency departments across the state, in-
cluding CVMC.  RAM allows for same-day treatment 
with buprenorphone to control withdrawal, while you 
are referred to a MAT provider and connected with a 
Recovery Coach.  Questions about RAM and whether 
it’s available in an emergency room near you can be 
answered by the confidential clinician’s line, (802)371-
4190.
Rapid Access to MAT, https://cvmc.org/our-services/emergen-
cy-department/rapid-access-mat-ram
Where can I get Narcan®/naloxone?
WARNING - You may need two or more doses 
available.  It’s advisable to have multiple naloxone doses 
on hand, due to the overdose potential of fentanyl and 
fentanyl-contaminated drugs.  It is not uncommon for 
a person in overdose to respond to a first dose of nalox-
one only to lose consciousness once again and require a 
second dose.  
WARNING - Call 9-1-1 after administering a dose of 
Narcan to anyone.  The person may not be stable, and 
it’s state law to help keep them safe.  You are immune 
from civil or criminal liability when giving naloxone, so 
long as you don’t act recklessly, with gross negligence, or 
intentional misconduct.
Where you can get naloxone:
•  All pharmacies in Vermont are required to make 
naloxone available on request, but there may be some 
charge.  Medicaid or insurance may apply.  
•  The Opioid Overdose Prevention and Reversal Project 
makes emergency overdose rescue kits  and overdose 
response training available free of charge at a range of 
locations.  A list and map of locations may be found at 
the web address below.
NARCAN/NALOXONE OVERDOSE RESCUE
https://www.healthvermont.gov/response/alcohol-drugs/nar-
can-naloxone-overdose-res
Where can I begin MAT?
You can receive live help to find treatment programs by 
dialing 2-1-1 in Vermont or visiting Vermont211.org.
Medication Assisted Treatment (MAT) uses a “hub-and-
spoke” model and starts at an Opioid Treatment Hub, 
where you will be evaluated and begin receiving medica-
tions such as buprenorphine to prevent withdrawal and 
reduce cravings.  Eventually, your medications will be 
managed at the “spoke” office that is most convenient for 
you.  Please bring ID and be prepared to submit a urine 
sample - the screening evaluation takes 1-2 days.  
Specific options in Central Vermont can be seen below.  
For beginning MAT, known as induction, it is recom-
mended to visit one of the walk-in clinics.
BAART Programs Berlin
617 Comstock Rd, Suite 5
Berlin, VT 05602
(802)223-2003
Walk-in Clinic Hours: Monday - Friday 7am - 8pm
Treatment Associates, Inc. - Montpelier Office
73 Main Street, Suite 27
Montpelier, VT 05602
(802)225-8355
Walk-in Clinic Hours: Tues & Thurs 1:30 - 2:30pm
Treatment Associates, Inc. - Morrisville Office
65 Portland Street, PO Box 1099
Morrisville, VT 05661
(802)888-0079
Walk-in Clinic Hours: Tues & Thurs 1:30 - 2:30pm
CVMC MAT Program
84 East View Lane, Suite 2
Barre VT 05641
(802)371-4875 
Hours 8AM - 4:30 PM
Gifford Healthcare
44 South Main Street
Randolph, VT 05060
(802)728-7000
“Vermont Substance Abuse Treatment & Recovery Directory”
Division of Alcohol & Drug Abuse Programs
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